Rerefined model
PDB 5U6I|dpdb_61q7sbpu
Rerefined model
Discovery of MLi-2, an Orally Available and Selective LRRK2 Inhibitor that Reduces Brain Kinase Activity
- Program
- PHENIX 2.0_5824
- Model type
- Multiconformer
- Purpose
- Refinement
- Atoms
- 3,154
- Residues
- 339
- Protein chains
- 1
- Alternate-location fraction
- 0.29%
- Ligands
- 81Y, SO4
Evaluations
R-work
0.173
R-free
0.207
Clashscore
3.0
Macromolecules
The same in every model of this entry.
Data
L0 Raw
L1 Processed
L2 Models
L3 Evaluations